Us Bancorp \De\ Red Hill Biopharma Ltd. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	BUY	$4.55 - $10.36 $3,194 - $7,272	702 New	702 $3,000
Q1 2021 Apr 28, 2021	SELL	$6.98 - $11.29 $1,186 - $1,919	-170 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$7.81 - $10.39 $476 - $633	61 Added 55.96%	170 $1,000
Q3 2020 Nov 10, 2020	BUY	$6.34 - $10.83 $691 - $1,180	109 New	109 $1,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.